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In many ways, the Human Genome Project has been more
successful than even its supporters might have expected.
It has come in ahead of schedule with its flagship goal of
providing a draft human sequence, and the genetic and
physical maps generated have been put to spectacular use
in identifying the genetic bases of scores of single-locus
diseases. For these genetically simple diseases it is possi-
ble to determine the rough genomic position of the causal
mutation by comparing the co-inheritance of variable
marker loci and the disease through affected pedigrees
with a methodology, linkage analysis, which is now routine.
Unfortunately, the common diseases responsible for the
vast majority of mortality and morbidity in the developed
world are anything but simple.
Most cancers and cardiovascular, neuro-psychiatric, respir-
atory and infectious diseases are influenced by variation at
multiple loci and show complicated dependence on envi-
ronmental factors. This complexity is also reflected in large
inter-individual variation in response to therapeutic treat-
ment. As adverse drug reactions are responsible for more
than 100,000 deaths each year in the US alone [1], variable
drug reaction itself ranks as one of the primary challenges
of contemporary biomedical research. In short, it is no time
for triumphalism. The greatest challenges in human
genetics remain ahead.
Population-based approaches
While linkage analysis may still have a part to play to meet
these challenges, a promising alternative approach turns
from families to populations, and from linkage analysis to
association studies. As illustrated in the recent paper by
Eric Lander, David Reich and colleagues [2], the shift to
association studies makes the description of genetic varia-
tion in human populations a pre-requisite for the develop-
ment of effective mapping strategies. The basic approach
used in an association study is straightforward. For example,
to test the involvement of a single nucleotide polymor-
phism (SNP) in a specific condition, allele frequencies are
compared in affected and un-affected individuals (or cases
and controls). One advantage of a population-based associ-
ation study, particularly in a case-control design, is that
individuals can be selected to match environmental
factors, such as age or lifestyle, that may also be important
in the disease. Another is that risks can be properly assessed
against the genetic and environmental ‘background’ of the
population under study.
If we could test all candidate sites in this way, it would be
possible to identify those variants that influence both the
common diseases and variable drug reactions. In fact, simple
theoretical calculations indicate that an allele resulting in a
relative risk of two could be identified in this framework
[3]. But we are a long way from knowing all the SNPs,
even in any given population. Important subsets of SNPs
will appear sooner, for example all coding SNPs. Even for
such a restricted set, however, exhaustive typing in large
case-control studies would currently be prohibitively expen-
sive as a routine procedure. 
Linkage disequilibrium in association studies
So if exhaustive typing is currently prohibitive, techni-
cally and economically, in most situations, what can be
done? We have noted that SNP frequencies will differ if
the SNP influences the trait. But a SNP variant could also
be associated with the condition not because it is biologi-
cally causal, but because it is statistically correlated with a
causal variant. This possibility arises because alleles at
different loci are sometimes found together more or less
often than expected based on their frequencies. In popula-
tion genetics, this non-random pattern is called linkage
disequilibrium.
To see how linkage disequilibrium could be used to map
disease genes, consider a marker locus M, with two alleles
M1 and M2, and an unknown causative locus B, with one
allele B1 that is a risk factor for high blood pressure relative
to the other allele B2. We expect B1 to be elevated in cases
relative to controls. Now imagine that the M and B loci are
in disequilibrium, and specifically that the M1 allele is
more often found with the B1 allele than the B2 allele. In
that case, not only B1 is elevated in cases, but M1 is too
because of its association with B1. Thus if we did not know
about the B locus, but typed the M locus, it could lead us
to the B locus. But what exactly does such an association
indicate? And how should we distribute markers through
the genome in order to find causal variants?
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Linkage disequilibrium in human populations
Lander and colleagues [2] have taken an important step
toward addressing these questions. While there have been
a number of studies of linkage disequilibrium in the past
several years, most of them focused on relatively few
markers in only one or a few genomic regions, limiting the
utility of the results. Lander and colleagues [2] have taken
the first post-genome approach, assessing associations at
uniformly spaced intervals across 160 kilobases (kb) in
each of 19 genomic regions, in samples from three popula-
tions. Presumably to match conditions to mapping studies,
Lander and colleagues [2] used a ‘core’ coding SNP to
anchor each of the 19 regions. To identify SNPs at appro-
priate distances, resequencing was carried out on 2 kb
intervals spaced at 1, 5, 10, 20, 40, 80 and 160 kb in a single
direction from each core SNP. Discovery was carried out
in set of 44 unrelated individuals from Utah. The core
SNPs and newly identified SNPs were then typed in
Swedish and Nigerian samples. 
Lander and colleagues [2] emphasize several important
features of these data. Foremost is the considerable dis-
tance over which appreciable linkage disequilibrium occurs.
Specifically, they show that a simple measure of linkage
disequilibrium (D′) retains an average absolute value above
0.5 between sites separated by up to 60 kb in Northern
Europe. While the amount of linkage disequilibrium nec-
essary for mapping would depend on the sample size and
the relative risk of causal variants, a D′ of 0.5 would be a
‘usable’ [4] amount of linkage disequilibrium in some
study designs. Interestingly, in the Nigerian sample,
linkage disequilibrium was found to extend about an order
of magnitude less far than in the Europeans, with the
average D′ dropping below 0.5 at less than 5 kb.
As suggested by Reich et al. [2], the genomic extent of
European linkage disequilibrium makes systematic and
exhaustive gene mapping based on linkage disequilibrium
a realistic prospect, as markers could be spaced every 60 kb,
a roughly 20-fold reduction over theoretical predictions
that assume no extreme demographic events in recent
human history [4]. But extensive linkage disequilibrium is
not strictly salutary; while it reduces the necessary scale of
genome-wide screens, it can also make fine mapping more
difficult. The limited linkage disequilibrium in Nigeria,
however, is interesting in this regard. If such wide discrep-
ancies in the extent of linkage disequilibrium among
human populations holds up under further study, it should
be possible to carry out coarse mapping in populations
with more extensive linkage disequilibrium and fine
mapping in populations with less extensive linkage dise-
quilibrium [5], assuming that genetic causation is suffi-
ciently similar across populations. The importance of
populations with different characteristics extends to the
use of populations with different patterns of linkage
disequilibrium to test whether associated variants are
causal, as well as the use of putatively homogenous popu-
lations to reduce genetic heterogeneity and thereby increase
the power of detection of variants with moderate effect.
Variance of linkage disequilibrium
While it has attracted most attention in the literature, the
average extent of linkage disequilibrium is not the only
issue. More important is the variance of linkage disequilib-
rium as a function of distance between sites. Consider two
different scenarios, both consistent with the average values
across regions reported by Reich et al. [2]. In the low vari-
ance scenario, in a given region, all sites separated by less
than say 10 kb are almost always in strong linkage disequi-
librium, while sites farther than say 20 kb never are. In the
high variance scenario, the full range of linkage disequilib-
rium values are observed in both distance classes, but with
a greater tendency toward higher values at shorter distances.
How would this difference affect study design and interpre-
tation? Under the low variance scenario, a single marker
would ‘mark off’ a 10 kb interval, because it would be very
likely to be in linkage disequilibrium with any variant within
that interval. Perhaps even more importantly, under this sce-
nario, when an association is observed it means that the
causal variant cannot be farther away than 20 kb. Under the
high variance scenario, however, neither of these conditions
obtain. A single marker is insufficient to mark off the 10 kb
interval because it cannot be counted upon to be in linkage
disequilibrium with any given variant within the interval,
and if an association is observed it is possible that the causal
variant is a long way away. Thus the average extent of
linkage disequilibrium is only the first step, and in fact the
easiest. While we do not yet know which scenario is gener-
ally closer to reality, and whether it differs among popula-
tions, we have examples which appear closer to each [6,7].
The greater contribution of the Reich et al. [2] study
therefore is what it can tell us about the variance of linkage
disequilibrium. Because multiple sites in multiple regions
are considered, these data will provide the best picture yet
of the distribution of linkage disequilibrium as a function
of distance in multiple genome regions, which will greatly
facilitate the design of future studies. The data will con-
tribute to the evaluation of factors influencing linkage dis-
equilibrium, and can help assess how well patterns in
genomic regions that are not yet studied can be predicted
from those that have been studied. In fact, the importance
of variation in recombination is already highlighted by the
reported correlation with the extent of linkage disequilib-
rium [2]. Future studies will be required to assess other
factors, such as gene proximity.
The importance of the distribution of linkage disequilibrium
raises the question of power in association studies, which
currently lacks an appropriate framework for discussion.
When an association study is carried out using an incomplete
set of SNPs, we are interested in the extent to which the
SNPs that are typed ‘cover’ those that are not through
linkage disequilibrium. Knowledge of the distribution of
linkage disequilibrium in particular genomic regions will
provide the missing ingredient for assessing coverage. For
example, Figure 1 shows the nine SNPs described in the
database dbSNP (http://www.ncbi.nlm.nih.gov/SNP) that
fall within the transcribed region of the AGTR2 gene. The
ovals represent an arbitrarily chosen average extent of
linkage disequilibrium (in this case very short for the sake of
illustration). In addition to these known SNPs, in any given
population there is likely to be another set of SNPs that are
not currently known. If we were to type only the known
SNPs, we face the question of whether these would be suffi-
cient to detect the presence of unknown SNPs with some
specific relative risk in a given study design. As drawn here,
we would have a chance of detecting SNPs within the tran-
scribed region, but we might well miss something lurking in
the regulatory region.
Regarding power of detection, under the low variance
scenario all sites within an oval in Figure 1 might be in full
linkage disequilibrium with the known SNPs. In this case
a study using only the known SNPs in AGTR2 would have
exactly as much power of detection as would a study
typing all the SNPs in this gene, which would therefore be
less efficient. Under the high variance scenario, however,
linkage disequilibrium might be much less consistent,
even over such short intervals as indicated here. In this
case, it might be necessary to have more than one known
SNP within each oval, or it might be necessary to ensure
that the ovals overlap, as they do in the third exon, to
obtain the desired power. Clearly regions near multiple
markers — where the ovals overlap — are better covered
than those near only a single SNP.
For all of these reasons, a detailed knowledge of the
variance of linkage disequilibrium will be essential in order
to develop an appropriate statistical framework for inter-
preting association studies. Such a framework will not only
aid study design and interpretation, but is also a prerequi-
site for being able to declare that a gene does not harbor an
unknown variant conferring a relative risk greater than
some specified level. Providing a systematic description of
linkage disequilibrium will not be a trivial undertaking.
The likelihood of variations across genomic regions due to
differences in genealogical history, recombination rates or
selection suggest that each region included in a geno-
type–phenotype association study should be assessed in its
own right in the relevant population. In other words, what
is ultimately needed is a genome project for linkage dise-
quilibrium. But just as with the Human Genome Project,
there are difficult questions about priority. Would it better
to concentrate first on the small fraction of the genome
represented by genes (accompanied by a generous upstream
interval to capture regulatory regions)? Given the impor-
tance of cross-population comparisons, would it be better
to gather less information from multiple populations, or to
develop more complete pictures of fewer populations and
build from there? 
Most likely the community will pursue a hybrid strategy,
for while we work out the optimal design for genome-wide
work we also want guidance for more focused studies in
the near term. For example, in certain cases relevant
pathways are known in detail — as in the case of the
renin–angiotensin pathway and variable efficacy of anti-
hypertensive drugs — and genes within them are appro-
priate starting points for genotype–phenotype association
studies. When exhaustive sets of SNPs finally do become
available, one might wonder whether linkage disequilib-
rium can then be ignored. The answer is no. Even then,
knowledge of the distribution of linkage disequilibrium
will be required in order to translate detected associations
between SNPs and phenotypes into quantitative state-
ments about the possible genomic locations of the causal
variant consistent with the observed associations.
Demography and linkage disequilibrium
Whatever the real patterns of linkage disequilibrium in
human populations, they have been shaped by our evolu-
tionary history. While linkage disequilibrium work is
clearly focused on the development and refinement of
mapping strategies, the data will also prove an unprece-
dented resource for evolutionary inference. For example,
based on an idealized model of human history, Kruglyak
[4] concluded that linkage disequilibrium would not extend
much beyond about 3 kb, but also noted that this could be
significantly greater in populations that have undergone a
severe bottleneck. Recent admixture has also been shown
to result in extended regions of linkage disequilibrium [5].
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Figure 1
Schematic representation of the angiotensin receptor 2 (AGTR2) gene
structure, showing locations of known SNPs. The ovals represent the
possible extent of linkage disequilibrium from each known SNP.
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Reich et al. [2] used a simulation approach to ask why the
patterns of linkage disequilibrium are so different in the
North European and Nigerian samples. They found that
admixture is unlikely to be the sole explanation, because
the linkage disequilibrium observed in Europeans is
greater than what admixture, even between distantly related
human populations, is likely to produce. 
Thus, it appears reasonable that a genetic bottleneck has
affected the European but not African populations. The
time of the bottleneck cannot be precisely pinned down.
Reich et al. [2] suggest that it may be associated with
founder events during the last glacial maximum in Europe,
which leads to the testable prediction that Northern Europe
has its own pattern of linkage disequilibrium, distinct from
that of other non-African populations. Alternatively, the
bottleneck could be associated with the emergence of
modern humans from Africa, in which case the pattern of
linkage disequilibrium it left would be shared among many
different human populations [8]. Of course, multiple demo-
graphic events may have contributed to linkage disequilib-
rium in any given population and the relative contributions
of such events could differ not only among populations,
but throughout the genome. For example, the effect of a
specific demographic event would last longer for tightly
linked than for loosely linked pairs of sites. Assessing the
demographic factors responsible for the linkage disequilib-
rium observed in Europe and elsewhere will require
further in depth studies on other populations. Reich et al.
[2] have provided an invaluable first step, but a compre-
hensive linkage disequilibrium map, of the whole genome
and in multiple populations, is still a long way away.
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